145 related articles for article (PubMed ID: 9780708)
21. Management of bleeding peptic ulcer: current status of intravenous proton pump inhibitors.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():7-12. PubMed ID: 15588788
[TBL] [Abstract][Full Text] [Related]
22. Prevention and treatment of stress ulcers in critically ill patients.
Yang YX; Lewis JD
Semin Gastrointest Dis; 2003 Jan; 14(1):11-9. PubMed ID: 12610850
[TBL] [Abstract][Full Text] [Related]
23. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Harris RA; Kuppermann M; Richter JE
Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
[TBL] [Abstract][Full Text] [Related]
24. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
25. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
Mazure PA
Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
[No Abstract] [Full Text] [Related]
26. Review article: prevention of stress-related mucosal bleeding with proton-pump inhibitors.
Maton PN
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():45-52. PubMed ID: 16303037
[TBL] [Abstract][Full Text] [Related]
27. Omeprazole versus ranitidine in the medical treatment of acute upper gastrointestinal bleeding: assessment by early repeat endoscopy.
Fasseas P; Leybishkis B; Rocca G
Int J Clin Pract; 2001 Dec; 55(10):661-4. PubMed ID: 11777288
[TBL] [Abstract][Full Text] [Related]
28. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
Lazzaroni M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
30. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
Huggins RM; Scates AC; Latour JK
Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
[TBL] [Abstract][Full Text] [Related]
31. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
Evseev MA; Ivakhov GB; Golovin RA
Khirurgiia (Mosk); 2009; (3):46-52. PubMed ID: 19391208
[No Abstract] [Full Text] [Related]
32. [The medical treatment of upper gastrointestinal bleeding in the new millennium].
Chermesh I; Eliakim R
Harefuah; 2002 Jan; 141(1):67-9, 125. PubMed ID: 11851112
[TBL] [Abstract][Full Text] [Related]
33. Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial.
Ono S; Kato M; Ono Y; Nakagawa M; Nakagawa S; Shimizu Y; Asaka M
Endoscopy; 2009 Apr; 41(4):299-303. PubMed ID: 19340731
[TBL] [Abstract][Full Text] [Related]
34. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
Lin HJ; Lo WC; Cheng YC; Perng CL
Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
[TBL] [Abstract][Full Text] [Related]
35. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine.
Walker S; Sarem-Aslani A; Treiber G; Klotz U; Bode JC
Neth J Med; 1991 Feb; 38(1-2):18-23. PubMed ID: 1674363
[TBL] [Abstract][Full Text] [Related]
36. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
De Natale G; De Natale F; Marino A
Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
[TBL] [Abstract][Full Text] [Related]
37. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
38. [Prevention of acute stress hemorrhages of the upper gastrointestinal tract with pirenzepine and antacids. A controlled comparison between pirenzepine and cimetidine].
Tryba M; Zevounou F; Grabhoefer P; Seifert V; Török M
Anasth Intensivther Notfallmed; 1984 Oct; 19(5):240-4. PubMed ID: 6393814
[TBL] [Abstract][Full Text] [Related]
39. [The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors].
Serebrova SIu
Klin Med (Mosk); 2007; 85(3):61-4. PubMed ID: 17523409
[TBL] [Abstract][Full Text] [Related]
40. Antisecretory therapy for bleeding peptic ulcer.
Peterson WL; Cook DJ
JAMA; 1998 Sep; 280(10):877-8. PubMed ID: 9739959
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
